Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in
There are no recent dividends present for DYN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.